Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas
- PMID: 19862564
- DOI: 10.1007/s10143-009-0228-y
Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas
Abstract
Prognosis of chordomas is difficult to predict based solely on histological findings. The purpose of this study was to assess expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and matrix metalloproteinase (MMP)-2, MMP-9 in skull base chordomas and to find out their correlations to outcome. Immunohistochemical study was performed in 19 samples (initial, n = 11; recurrent, n = 8) from 11 patients. The correlations among expression of RECK, MMP-2, MMP-9, and their prognostic values were analyzed. Significant correlation between RECK and MMP-9 was found, but there was no correlation found between MMP-2 and MMP-9. Higher MMP-9 expression significantly influenced outcome. Furthermore, MMP-9/RECK ratio showed significant correlation to outcome, showing their inverse relationship in the disease progress of skull base chordoma. RECK and MMP-9 can be valuable markers to predict prognosis in skull base chordomas.
Similar articles
-
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.Lung Cancer. 2007 Dec;58(3):376-83. doi: 10.1016/j.lungcan.2007.07.004. Epub 2007 Aug 21. Lung Cancer. 2007. PMID: 17714826
-
Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.Arch Oral Biol. 2017 Mar;75:62-67. doi: 10.1016/j.archoralbio.2016.12.009. Epub 2016 Dec 26. Arch Oral Biol. 2017. PMID: 28043014
-
Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.Hum Pathol. 2007 Nov;38(11):1603-10. doi: 10.1016/j.humpath.2007.03.018. Epub 2007 Jul 31. Hum Pathol. 2007. PMID: 17669467
-
RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).Anticancer Agents Med Chem. 2012 Sep;12(7):718-25. doi: 10.2174/187152012802650237. Anticancer Agents Med Chem. 2012. PMID: 22292753 Review.
-
[Chordoma].Neurochirurgie. 2014 Jun;60(3):63-140. doi: 10.1016/j.neuchi.2014.02.003. Epub 2014 May 23. Neurochirurgie. 2014. PMID: 24856008 Review. French.
Cited by
-
Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions.J Neurooncol. 2012 May;107(3):559-64. doi: 10.1007/s11060-011-0778-z. Epub 2011 Dec 20. J Neurooncol. 2012. PMID: 22183444
-
Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.Med Sci Monit. 2016 Jun 7;22:1936-8. doi: 10.12659/msm.896546. Med Sci Monit. 2016. PMID: 27272560 Free PMC article.
-
Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.Front Oncol. 2022 Sep 29;12:997506. doi: 10.3389/fonc.2022.997506. eCollection 2022. Front Oncol. 2022. PMID: 36248987 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous